» Articles » PMID: 32899838

Myeloperoxidase and Lysozymes As a Pivotal Hallmark of Immunity Status in Rabbits

Overview
Journal Animals (Basel)
Date 2020 Sep 9
PMID 32899838
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Infectious diseases, due to their massive scale, are the greatest pain for all rabbit breeders. Viral infections cause enormous economic losses in farms. Treating sick rabbits is very difficult and expensive, so it is very important to prevent disease by vaccinating. In order to successfully fight viral infections, it is important to know about the immune response of an infected animal. The aim of this study was to analyze the immune response mediated by antimicrobial peptides (myeloperoxidase (MPO) and lysozyme (LZM)) in peripheral blood neutrophils and rabbit serum by non-invasive immunological methods. The study was carried out on mixed breed rabbits that were experimentally infected with two strains (Erfurt and Rossi) of the /GI.1a virus. It has been observed that virus infection causes changes in the form of statistically significant increases in the activity of MPO and LZM concentration, while in the case of LZM activity only statistically significant decreases were noted. Additionally, clinical symptoms typical for the course of the disease were noted, and the probability of survival of the animals at 60 h p.i. (post infection) was 30% for the Erfurt strain, and -60% for the Rossi strain. The obtained results of MPO and LZMs suggest that these enzymes, especially MPO, may serve as a prognostic marker of the state of the immune system of rabbits.

Citing Articles

MicroRNAs Regulate the Expression of Genes Related to the Innate Immune and Inflammatory Response in Rabbits Infected with GI.1 and GI.2 Genotypes.

Ostrycharz-Jasek E, Fitzner A, Siennicka A, Budkowska M, Hukowska-Szematowicz B Int J Mol Sci. 2024; 25(17).

PMID: 39273479 PMC: 11394960. DOI: 10.3390/ijms25179531.


Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the Humoral Immune Protection Effect of VP60 Vaccine.

Li Z, Song K, Du Y, Zhang Z, Fan R, Zheng P Curr Issues Mol Biol. 2023; 45(8):6605-6617.

PMID: 37623236 PMC: 10453004. DOI: 10.3390/cimb45080417.


Occurrence of Lagovirus europaeus (Rabbit Hemorrhagic Disease Virus) in Domestic Rabbits in Southwestern Poland in 2019: Case Report.

Hrynkiewicz R, Bebnowska D, Kauppinen A, Gadd T, Piasecki T, Niedzwiedzka-Rystwej P Microbiol Spectr. 2022; 10(6):e0229822.

PMID: 36445093 PMC: 9769870. DOI: 10.1128/spectrum.02298-22.


Immunity against and the Impact of the Immunological Studies on Vaccination.

Muller C, Hrynkiewicz R, Bebnowska D, Maldonado J, Baratelli M, Kollner B Vaccines (Basel). 2021; 9(3).

PMID: 33805607 PMC: 8002203. DOI: 10.3390/vaccines9030255.

References
1.
Silverio D, Lopes A, Melo-Ferreira J, Magalhaes M, Monterroso P, Serronha A . Insights into the evolution of the new variant rabbit haemorrhagic disease virus (GI.2) and the identification of novel recombinant strains. Transbound Emerg Dis. 2018; 65(4):983-992. DOI: 10.1111/tbed.12830. View

2.
Niedzwiedzka-Rystwej P, Deptula W . Lymphocyte subpopulations and apoptosis of immune cells in rabbits experimentally infected with a strain of the RHD virus having a variable haemagglutination capacity. Pol J Vet Sci. 2012; 15(1):43-9. DOI: 10.2478/v10181-011-0112-x. View

3.
Huang H . Vaccination against and immune response to viral haemorrhagic disease of rabbits: a review of research in the People's Republic of China. Rev Sci Tech. 1991; 10(2):481-98. View

4.
Strzepa A, Pritchard K, Dittel B . Myeloperoxidase: A new player in autoimmunity. Cell Immunol. 2017; 317:1-8. PMC: 5665680. DOI: 10.1016/j.cellimm.2017.05.002. View

5.
Abrantes J, Lopes A, Dalton K, Melo P, Correia J, Ramada M . New variant of rabbit hemorrhagic disease virus, Portugal, 2012-2013. Emerg Infect Dis. 2013; 19(11):1900-2. PMC: 3837648. DOI: 10.3201/eid1911.130908. View